Ten-year experience in the clinical management of intralobar pulmonary sequestration in children

Pediatr Pulmonol. 2023 Apr;58(4):1022-1027. doi: 10.1002/ppul.26287. Epub 2022 Dec 28.

Abstract

Objectives: Intralobar pulmonary sequestration (ILS) is rare and its optimal clinical management remains ambiguous. This study aimed to introduce our 10-year experience in clinical management of ILS. And the application of our novel surgical method, thoracoscopic anatomical lesion resection (TALR) on ILS was introduced.

Materials and methods: Patients with ILS who received treatment between December 2010 and 2020 were included in this study, retrospectively. A binary logistic regression model was used to assess risk factors for preoperative symptoms. Intraoperative and postoperative outcomes were compared between the thoracoscopic lobectomy and lung-sparing surgery groups.

Results: A total of 112 patients were included in this study. Age and maximum cyst diameter were risk factors for preoperative symptoms. Lung-sparing surgery proved to be safe and feasible with no residual lesions.

Conclusions: The overall prognosis of early thoracoscopic surgery for ILS was good. Lung-sparing surgery, especially TALR could be used as a first-line surgery for ILS. It may resolve the long-standing controversy over whether surgery for asymptomatic patients with ILS.

Keywords: children; congenital lung malformation; intralobar pulmonary sequestration; thoracoscopic surgery.

MeSH terms

  • Bronchopulmonary Sequestration* / diagnosis
  • Bronchopulmonary Sequestration* / surgery
  • Child
  • Cysts*
  • Humans
  • Retrospective Studies
  • Risk Factors
  • Thoracoscopy